Page last updated: 2024-12-05

strontium carbonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Strontium carbonate (SrCO3) is a white inorganic compound that occurs naturally as the mineral strontianite. It is primarily synthesized by reacting strontium hydroxide with carbon dioxide. Strontium carbonate is used in various applications, including the production of fireworks, glass, and ceramics. It is also used in the sugar refining industry. Strontium carbonate is a valuable compound for its unique optical properties. It is particularly used in the manufacture of high-quality glass and ceramics, where it contributes to their brilliance and durability. Moreover, it is a key component in pyrotechnic formulations, providing the distinctive red color in fireworks. In scientific research, strontium carbonate is utilized as a reagent in organic synthesis and as a starting material for producing other strontium compounds. The compound has been found to be biocompatible, making it suitable for biomedical applications, including bone grafting and drug delivery. Ongoing research on strontium carbonate focuses on its potential applications in environmental remediation, such as the removal of heavy metals from contaminated water. '

Cross-References

ID SourceID
PubMed CID15407
CHEMBL ID3188467
SCHEMBL ID48480
MeSH IDM0153377

Synonyms (49)

Synonym
carbonic acid strontium salt (1:1)
strontium carbonate
carbonic acid, strontium salt (1:1)
c.i. 77837
strontium carbonate (srco3)
nsc-112224
1633-05-2
41ypu4mmca ,
unii-41ypu4mmca
ec 216-643-7
co3sr
AKOS015836320
strontium carbonate, >=99.9% trace metals basis
strontium carbonate, 99.995% trace metals basis
strontium carbonate, >=98%
strontianite
ci 77837
einecs 216-643-7
ccris 3203
nsc 112224
hsdb 5845
dtxcid009651
NCGC00260323-01
dtxsid3029651 ,
tox21_202776
cas-1633-05-2
FT-0688133
strontium carbonate [hsdb]
strontium carbonicum
strontium carbonas
strontium carbonate [mi]
strontium carbonicum [hpus]
strontium carbonas [who-dd]
SCHEMBL48480
LEDMRZGFZIAGGB-UHFFFAOYSA-L
CHEMBL3188467
mfcd00011250
strontium carbonate (low alkali and heavy metals)
strontium carbonate, puriss., >=97.0%
strontium carbonate, technical grade
strontium carbonate, nist(r) srm(r) 987, isotopic standard
strontium carbonate, p.a., 97.0%
srco3
J-010031
formic-14c acid(6ci,7ci,8ci,9ci)
Q413629
strontium carbonate powder
strontium carbonate submicron
strontium;carbonate

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"The objective of the present study was to incorporate strontium into calcium phosphate cement combined with a lower single-dose local administration of bone morphogenetic protein-2 to enhance its in vivo biodegradation and bone tissue growth."( Effects of strontium-modified calcium phosphate cement combined with bone morphogenetic protein-2 on osteoporotic bone defects healing in rats.
Jiang, Y; Tao, Z; Wu, X; Xie, J; Xu, Z; Yang, M; Zhou, W, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (19)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency3.44210.007215.758889.3584AID1224835
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency3.35343.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency2.96290.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency1.64200.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency1.47840.000221.22318,912.5098AID1259243; AID1259381; AID743035
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency2.96290.000657.913322,387.1992AID1259377
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency2.71890.001022.650876.6163AID1224838; AID1224893
progesterone receptorHomo sapiens (human)Potency0.37300.000417.946075.1148AID1346784
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency2.75950.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency3.35340.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency0.39550.001530.607315,848.9004AID1224841; AID1224842
estrogen nuclear receptor alphaHomo sapiens (human)Potency1.23150.000229.305416,493.5996AID1259244; AID1259248; AID743079
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency1.88570.001024.504861.6448AID743215
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency3.45270.023723.228263.5986AID743222; AID743241
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency2.12200.057821.109761.2679AID1159526; AID1159528
Histone H2A.xCricetulus griseus (Chinese hamster)Potency4.88270.039147.5451146.8240AID1224845
heat shock protein beta-1Homo sapiens (human)Potency3.35340.042027.378961.6448AID743210; AID743228
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency0.52690.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency0.52690.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (5.26)18.7374
1990's2 (5.26)18.2507
2000's12 (31.58)29.6817
2010's20 (52.63)24.3611
2020's2 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 56.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index56.06 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index5.29 (4.65)
Search Engine Demand Index89.08 (26.88)
Search Engine Supply Index2.05 (0.95)

This Compound (56.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other39 (97.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]